Applied DNA Sciences Changes Ticker Symbol to BNBX Reflecting Digital Asset Strategy
ByAinvest
Monday, Oct 6, 2025 8:05 am ET1min read
APDN--
The new ticker symbol "BNBX" reflects the company's strategic shift towards integrating actively managed decentralized finance (DeFi) protocols and Binance ecosystem-specific strategies. These efforts are designed to enhance capital efficiency, liquidity resilience, and exposure to digital asset upside. The company plans to deploy a differentiated approach to treasury management, leveraging the Binance ecosystem to maximize the benefits of its digital asset holdings.
No action is required from the company's stockholders regarding the ticker symbol change. The common stock will continue to be listed on Nasdaq, and the CUSIP number will remain unchanged. Investors are advised to update their records to reflect the new ticker symbol.
Applied DNA Sciences is a biotechnology company that executes a yield-focused BNB digital asset treasury strategy while also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
BNB--
Applied DNA Sciences is changing its ticker symbol from "APDN" to "BNBX" on the Nasdaq Capital Market on October 7, 2025. The new ticker symbol reflects the company's strategic commitment to a BNB-based treasury strategy, aiming to optimize yield generation and token accumulation within the Binance ecosystem. The company plans to integrate actively managed decentralized finance protocols and Binance ecosystem-specific strategies to enhance capital efficiency, liquidity resilience, and exposure to digital asset upside. No action is required from stockholders, and the common stock will continue to be listed on Nasdaq with an unchanged CUSIP number.
Applied DNA Sciences, Inc. (NASDAQ: APDN) has announced a significant change in its ticker symbol. Effective October 7, 2025, the company's ticker on the Nasdaq Capital Market will change from "APDN" to "BNBX" [1]. This change underscores the company's strategic commitment to a Binance Coin (BNB)-based treasury strategy, aiming to optimize yield generation and token accumulation within the Binance ecosystem.The new ticker symbol "BNBX" reflects the company's strategic shift towards integrating actively managed decentralized finance (DeFi) protocols and Binance ecosystem-specific strategies. These efforts are designed to enhance capital efficiency, liquidity resilience, and exposure to digital asset upside. The company plans to deploy a differentiated approach to treasury management, leveraging the Binance ecosystem to maximize the benefits of its digital asset holdings.
No action is required from the company's stockholders regarding the ticker symbol change. The common stock will continue to be listed on Nasdaq, and the CUSIP number will remain unchanged. Investors are advised to update their records to reflect the new ticker symbol.
Applied DNA Sciences is a biotechnology company that executes a yield-focused BNB digital asset treasury strategy while also commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet